| Quantitative assessment of collagenase blends for human islet isolation. | |
| | |
MedLine Citation:
|
PMID: 16210957 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: The variability in collagenase blends has been speculated as the single most important determinant of the success or failure in isolated islet yields in clinical islet transplantation. Examination of the formulation and potency of the widely used Liberase HI enzyme blend will uncover possible sources of imprecision. METHODS: High performance liquid chromatography (HPLC) and kinetic measurements of collagenase and protease activity were used to assess potency. Between four and nine clinical lots were assessed for various parameters such as relative formulation of collagenase isoforms, and recovered collagenase and protease potencies postreconstitution. RESULTS: Six vials from a single typical lot had a mean enzyme content of 489+/-62.5 mg (mean+/-SEM; range 398-610 mg). The mean recovered collagenase activity was 2235+/-310 Wünsch units (WU)/vial (range 1794-2968 WU/vial). The percent coefficients of variation for collagenase and protease activity in these vials were 17.4%, and 13.4%, respectively. The increase in the presence of the collagenase Ib (CIb) isoform detected by HPLC analysis was related to the chronological order of the date of manufacture. The CIb isoform was found to have a reduced specific activity compared to intact collagenase I (CI) (3.8+/-1.2 WU/mg vs. 2.1+/-0.7 WU/mg, P < 0.05). The presence of CIb was related to reduced islet yields in twelve human isolations studied. CONCLUSIONS: Variation in potency was observed between, and within lots of Liberase HI in this study. Differences in relative collagenase isoform composition may also affect the stability and potency characteristics of these blends. |
| | |
Authors:
|
Matthew J Barnett; Xiaojun Zhai; Donald F LeGatt; Siew Bang Cheng; A M James Shapiro; Jonathan R T Lakey |
Related Documents
:
|
9596147 - Sample dilution: a methodological pitfall in the measurement of tissue but not serum ac... 15137707 - Indications of hormonally active substances in municipal solid waste leachate: mobiliza... 17532157 - Antimicrobial activity of the methanolic extracts and compounds from treculia obovoidea... 17867637 - Flavonoids in horse chestnut (aesculus hippocastanum) seeds and powdered waste water by... 19280607 - Acetone, butanone, pentanone, hexanone and heptanone in the headspace of aqueous soluti... 20873797 - Application of inkjet printing technology to produce test materials of 1,3,5-trinitro-1... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Transplantation Volume: 80 ISSN: 0041-1337 ISO Abbreviation: Transplantation Publication Date: 2005 Sep |
Date Detail:
|
Created Date: 2005-10-07 Completed Date: 2005-12-21 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0132144 Medline TA: Transplantation Country: United States |
Other Details:
|
Languages: eng Pagination: 723-8 Citation Subset: IM |
Affiliation:
|
Human Islet Investigations Laboratory, Surgical Medical Research Institute, University of Alberta, Edmonton, Alberta, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cell Separation
/
methods* Chromatography, High Pressure Liquid Collagenases / metabolism* Humans Islets of Langerhans / cytology* Islets of Langerhans Transplantation / methods* |
| Chemical | |
Reg. No./Substance:
|
EC 3.4.24.-/Collagenases |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Function of the vascular endothelial growth factor receptors Flt-1 and Flk-1/KDR in the alloimmune r...
Next Document: Validation of large particle flow cytometry for the analysis and sorting of intact pancreatic islets...